Aims & Scope
Current Neuropharmacology aims to provide current, timely and comprehensive reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
Ranking and Category
72th of 256 in Neuroscience
24th of 253 in Pharmacology & Pharmacy
Bentham Press Release —NEWS!!!
- New Issue Published Current Neuropharmacology Vol. 16 Issue 3
- New Issue Published Current Neuropharmacology Vol. 16 Issue 1
- New Issue Published Current Neuropharmacology Vol. 15 Issue 8
- Free Trial Request
- Most Accessed Article : Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
- New Issue Published Current Neuropharmacology Vol. 15 Issue 7
- Open Access Article: Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression
- New Issue Published Current Neuropharmacology Vol. 15 Issue 6
- Most Accessed Article:Melatonin: Pharmacology, Functions and Therapeutic Benefits
- New Issue Published Current Neuropharmacology Vol. 15 Issue 5
- Open Access Article : Animal Models of Maternal Immune Activation in Depression Research
- Call For Paper
- Free Trial Request
- Most Accessed Article : The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant
- Open Access Article: Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
- Call For Paper
- New Issue Published Current Neuropharmacology Vol. 15 Issue 4
- Free Trial Request
- Open Access Article: Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
- Most Accessed Article: Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
- Call For Paper
- Issue Published Current Neuropharmacology 15 Issue 3
- Free Trial Request
- Open Access Article: Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
- Most Accessed Article: Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
- Free Online Issue Current Neuropharmacology Vol. 15 Issue 1
- Call For Paper
- Free Trial Request
- Issue Published Current Neuropharmacology Vol. 15 Issue 2
- Most Accessed Article: Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
- Highlighted Article: Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets
- Most Cited Article: Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease
- Most Accessed Article: Probiotics as an Adjuvant Therapy in Major Depressive Disorder
- Call For Paper
- Free Trial Request
- Issue Published Current Neuropharmacology Vol.15 Issue 1
- Podcast for (The Role of Ionotropic Glutamate Receptors in Childhood Neurodevelopmental Disorders: Autism Spectrum Disorders and Fragile X Syndrome)
- Free Online Issue of Current Neuropharmacology
- Highlighted Article: Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol
- Free Trial Request
- Call For Paper
- Highlighted Article: Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis
- Most Accessed Article: Drug Therapy for Behavioral and Psychological Symptoms of Dementia
- Free Trial Offer
- Editorial (Thematic Selection: Strategies of Current Drugs and Alternative Treatments for Neurodegenerative Diseases)
- Podcast Autism Spectrum Disorders and Fragile X Syndrome
- Current Neuropharmacology Volume 14, 4
-
Highlighted Article Flyer for the journal “Current Neuropharmacology”
-
Highlighted Article Flyer for the journal “Current Neuropharmacology” Volume 14 Number 5
-
Highlighted Article Flyer for the journal “Current Neuropharmacology” Volume 14, Number 6
Advertisements
